Projects per year
Fingerprint
Dive into the research topics where Marcos Garcia de Lima is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Trispecific CAR-T cells targeting CD19, CD20 and CD22 to treat B-cell malignancies
Vasu, S. (PI), Alinari, L. (CoPI) & Garcia de Lima, M. (CoPI)
07/21/23 → 06/30/25
Project: Research
-
Case BMT CTN: Antibacterial Prophylaxis in Post-Engraftment Allogeneic HCT
Garcia de Lima, M. (PI) & Lazarus, H. (CoPI)
08/8/11 → 06/30/16
Project: Research
-
-
Measurable residual disease testing and allogeneic hematopoietic cell transplantation for AML: adapting Pre-MEASURE to clinical practice
Shaffer, B. C., Kebriaei, P., de Lima, M. & Jimenez Jimenez, A. M., Feb 2025, In: Bone Marrow Transplantation. 60, 2, p. 128-134 7 p., 100996.Research output: Contribution to journal › Article › peer-review
Open Access -
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia
Hegde, P. S., Andrew, G., Gui, G., Ravindra, N., Mukherjee, D., Wong, Z. C., Auletta, J. J., El Chaer, F., Corner, A., Devine, S. M., Jimenez Jimenez, A. M., De Lima, M. J. G., Litzow, M. R., Kebriaei, P., Saber, W., Spellman, S. R., Zeger, S. L., Page, K. M., Dillon, L. W. & Hourigan, C. S., Feb 2025, In: Bone Marrow Transplantation. 60, 2, p. 175-177 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access3 Scopus citations -
Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysis
Bajwa, A., Zhao, Q., Geer, M., Lin, C., Westholder, J., Maakaron, J., Ghosh, M., Frame, D., Galal, A., Tossey, J., Ahmed, N., Bezerra, E., Denlinger, N., de Lima, M., Epperla, N., Caimi, P. & Voorhees, T., Jan 14 2025, In: Blood Advances. 9, 1, p. 170-175 6 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia
Metheny, L. L., Sobecks, R., Cho, C., Fu, P., Margevicius, S., Wang, J., Ciarrone, L., Kopp, S., Convents, R. D., Majhail, N., Caimi, P. F., Otegbeye, F., Cooper, B. W., Gallogly, M., Malek, E., Tomlinson, B., Gerds, A. T., Hamilton, B., Giralt, S. & Perales, M. A. & 1 others, , Mar 26 2024, In: Blood Advances. 8, 6, p. 1384-1391 8 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies
de Lima, M., Di Rocco, A. & Ribera, J. M., 2024, In: Frontiers in Oncology. 14, 1472463.Research output: Contribution to journal › Editorial
Open Access